Clinical Decision-Making (CDM) Cases Part I Practice Test

The main idea is to choose an antibiotic that covers beta-lactamase–producing pathogens in acute otitis media when there’s recent beta-lactam exposure or conjunctivitis. When a child has used a beta-lactam recently or has conjunctivitis, there’s a higher risk that the common middle-ear bacteria (like non-typeable Haemophilus influenzae and Moraxella catarrhalis) are producing beta-lactamases. Amoxicillin alone may be ineffective against these organisms, so you want an antibiotic that can inhibit those enzymes. Amoxicillin-clavulanate does exactly that by adding clavulanate, a beta-lactamase inhibitor, which broadens the spectrum and improves the chance of cure in this scenario. The other options either don’t provide this beta-lactamase coverage (cefdinir, azithromycin) or are reserved/less favorable for pediatric AOM due to safety and efficacy concerns (levofloxacin). So the preferred choice is amoxicillin-clavulanate.